The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
By launching a new series of silicone dressings that conform to the natural contours of the body, Coloplast (CPH-Colo-B) takes another step towards the goal of doubling the size of its Wound Care business by the 2020/21 financial year.
By launching a new series of silicone dressings that conform to the natural contours of the body, Coloplast (CPH-Colo-B) takes another step towards the goal of doubling the size of its Wound Care business by the 2020/21 financial year. The new series of silicone dressings is scheduled to launch starting in December and will launch in all key markets during 2016/2017.
Coloplast is expanding its Biatain Silicone portfolio with eight new wound dressings referred to as Sizes & Shapes. Used for treating chronic wounds, the dressings are shaped to fit a heel, the hollow of the knee, the back of the neck or the shoulder; places where it can be difficult to apply a dressing properly.
According to Nicolai Buhl, SVP of Coloplast’s Wound Care business, innovative products such as Sizes & Shapes form an important part of Coloplast’s growth plans.
– Our new silicone wound dressings give the competition a run for its money, while giving the users what they want: wound dressings that conform to the body’s natural shape. We’re confident that our new wound dressings, developed by healthcare professionals and shaped by users, will strengthen our position in the global wound care market, because we now have a complete product offering for many different wound types, says Nicolai Buhl.
Coloplast’s Wound Care business currently has a global market share of 5–10 percent. The company’s ambition is to grow to 10–15 percent by the 2020/21 financial year.
Facts
According to Nicolai Buhl, SVP of Coloplast’s Wound Care business, innovative products such as Sizes & Shapes form an important part of Coloplast’s growth plans.
– Our new silicone wound dressings give the competition a run for its money, while giving the users what they want: wound dressings that conform to the body’s natural shape. We’re confident that our new wound dressings, developed by healthcare professionals and shaped by users, will strengthen our position in the global wound care market, because we now have a complete product offering for many different wound types, says Nicolai Buhl.
Coloplast’s Wound Care business currently has a global market share of 5–10 percent. The company’s ambition is to grow to 10–15 percent by the 2020/21 financial year.
Facts
- The global market for wound care products is estimated at DKK 16–17 billion, and market growth is estimated at 3–5 percent per year.
- Coloplast’s Wound Care Business has a 5–10 percent global market share.
- The new Biatain Silicone Sizes & Shapes series builds on the existing Biatain Silicone portfolio.
Follow us at Facebook.com/ColoplastWoundCare and Linkedin.com/company/coloplast
Read more: Coloplast.com/products/wound/biatain-silicone–fewer-days-with-wounds/
         Contact:
Maria Lindeberg
Senior Media Relations Manager
Tel: + 45 49 11 30 95
dkmalg@coloplast.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â